An audit of hospital based outpatient infusions and a pilot program of community-based monoclonal antibody infusions.

Hdl Handle:
http://hdl.handle.net/10147/207690
Title:
An audit of hospital based outpatient infusions and a pilot program of community-based monoclonal antibody infusions.
Authors:
Doran, J-P; Alraqi, S; Callanan, I; FitzGerald, O; Bresnihan, B; Veale, D J
Affiliation:
Department of Rheumatology, St Vincent's University Hospital, Dublin, Ireland., johnpauldoran@gmail.com
Citation:
Ir J Med Sci. 2009 Dec;178(4):497-501.
Journal:
Irish journal of medical science
Issue Date:
1-Feb-2012
URI:
http://hdl.handle.net/10147/207690
DOI:
10.1007/s11845-008-0274-4
PubMed ID:
19129975
Abstract:
INTRODUCTION: Infliximab, a chimeric monoclonal antibody to tumour necrosis factor alpha, is administered as an intravenous infusion requiring a costly hospital day case or inpatient admission. METHODS: An audit of all current therapies given by intravenous infusions in an outpatient setting in St Vincent's University Hospital (SVUH) was undertaken. Furthermore, in conjunction with TCP homecare, we established in a general practise health clinic, the first Irish community infusion centre for the administration of infliximab in August 2006. RESULTS: All outpatient departments indicated that they would favour a centralized hospital infusion unit. There were no adverse events and the mean global satisfaction improved in the community infliximab infusion pilot programme of seven patients. CONCLUSION: This study suggests efficiencies in providing centralized infusion facilities, while the community based infusion of infliximab is feasible and safe in this small cohort and identifies the community infusion unit as a viable and cost efficient alternative for administration of infliximab.
Language:
eng
MeSH:
Adult; Ambulatory Care/*utilization; Antibodies, Monoclonal/*administration & dosage/economics; Community Health Centers; Female; Hospital Departments/*utilization; Humans; Infusions, Intravenous/*utilization; Ireland; Male; Middle Aged; Pilot Projects; Questionnaires
ISSN:
1863-4362 (Electronic); 0021-1265 (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorDoran, J-Pen_GB
dc.contributor.authorAlraqi, Sen_GB
dc.contributor.authorCallanan, Ien_GB
dc.contributor.authorFitzGerald, Oen_GB
dc.contributor.authorBresnihan, Ben_GB
dc.contributor.authorVeale, D Jen_GB
dc.date.accessioned2012-02-01T10:35:02Z-
dc.date.available2012-02-01T10:35:02Z-
dc.date.issued2012-02-01T10:35:02Z-
dc.identifier.citationIr J Med Sci. 2009 Dec;178(4):497-501.en_GB
dc.identifier.issn1863-4362 (Electronic)en_GB
dc.identifier.issn0021-1265 (Linking)en_GB
dc.identifier.pmid19129975en_GB
dc.identifier.doi10.1007/s11845-008-0274-4en_GB
dc.identifier.urihttp://hdl.handle.net/10147/207690-
dc.description.abstractINTRODUCTION: Infliximab, a chimeric monoclonal antibody to tumour necrosis factor alpha, is administered as an intravenous infusion requiring a costly hospital day case or inpatient admission. METHODS: An audit of all current therapies given by intravenous infusions in an outpatient setting in St Vincent's University Hospital (SVUH) was undertaken. Furthermore, in conjunction with TCP homecare, we established in a general practise health clinic, the first Irish community infusion centre for the administration of infliximab in August 2006. RESULTS: All outpatient departments indicated that they would favour a centralized hospital infusion unit. There were no adverse events and the mean global satisfaction improved in the community infliximab infusion pilot programme of seven patients. CONCLUSION: This study suggests efficiencies in providing centralized infusion facilities, while the community based infusion of infliximab is feasible and safe in this small cohort and identifies the community infusion unit as a viable and cost efficient alternative for administration of infliximab.en_GB
dc.language.isoengen_GB
dc.subject.meshAdulten_GB
dc.subject.meshAmbulatory Care/*utilizationen_GB
dc.subject.meshAntibodies, Monoclonal/*administration & dosage/economicsen_GB
dc.subject.meshCommunity Health Centersen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHospital Departments/*utilizationen_GB
dc.subject.meshHumansen_GB
dc.subject.meshInfusions, Intravenous/*utilizationen_GB
dc.subject.meshIrelanden_GB
dc.subject.meshMaleen_GB
dc.subject.meshMiddle Ageden_GB
dc.subject.meshPilot Projectsen_GB
dc.subject.meshQuestionnairesen_GB
dc.titleAn audit of hospital based outpatient infusions and a pilot program of community-based monoclonal antibody infusions.en_GB
dc.contributor.departmentDepartment of Rheumatology, St Vincent's University Hospital, Dublin, Ireland., johnpauldoran@gmail.comen_GB
dc.identifier.journalIrish journal of medical scienceen_GB
dc.description.provinceLeinster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.